December 2022 - Page 3 of 6 - CannabisNewsWire

MondayDec 19, 2022 4:20 pm

420 with CNW — Germany Could Trigger Domino Effect of Marijuana Legalization in Europe

While the United States and other areas spent the past two decades legalizing cannabis within their borders and launching multibillion dollar cannabis industries, Europe focused more on cannabis decriminalization. Unlike legalization, which made it possible to grow, process and sell cannabis without legal repercussions, cannabis decriminalization is simply intended to remove criminal charges from cannabis possession and use, but does not facilitate the marijuana trade. With states such as Colorado and California bringing in billions of dollars worth of cannabis sales taxes, countries across the Atlantic have begun taking notice. In a recent move that could trigger a domino effect…

MondayDec 19, 2022 12:00 pm

Policymaker Optimism for Real Estate Lending Trends Portends Blue Sky Opportunity for Mortgage Loan Facilitator REZYFi, Inc.

Real estate market watchers have been encouraged by recent trends in inflationary policy and lending policy analysis The mid-December Consumer Price Index report and the subsequent Federal Reserve funds rate decision fell in line with expectations that inflation may have passed its peak and is beginning to decline Real estate lenders expect mortgage rates to trend lower as a result of the policy news Miami-based REZYFi Inc., a mortgage lender working with traditional loans and non-traditional market sectors such as the cannabis industry, has been preparing to meet a very fast-growing residential mortgage origination opportunity REZYFi is working toward an…

MondayDec 19, 2022 4:20 am

420 with CNW — Report Documents Safety Risks Linked to Cash-Intensive Marijuana Businesses

The congressional marijuana banking reforms are in limbo. A report highlights one key issue that supporters argue makes legislation paramount: the fact that cash intensive marijuana dispensaries are seriously exposed to crime. While some think those entities are prone to burglary because thieves come for the product, other report that cash is the primary lure. Marijuana markets are the target of burglaries, including some that turned violent and even fatal in 2021. In less than five months, almost 100 shops in Washington state were robbed, leading to increased calls from lawmakers to pass the Secure and Fair Enforcement (SAFE) banking…

FridayDec 16, 2022 4:20 pm

420 with CNW — Veterans’ Organizations Urge Congress to Approve Medical Cannabis Research Bill

Last week, a syndicate of more than 20 veterans’ service organizations forwarded a letter to congressional leaders, urging them to approve the VA Medicinal Cannabis Research Act before the end of the current session. The organizations included Disabled American Veterans, AMVETS and Iraq and Afghanistan Veterans of America. These veterans’ service organizations want legislators to pass the cannabis and veterans research legislation, which would make it necessary for the Department of Veterans Affairs to carry out clinical trials studying the therapeutic potential of marijuana for military veterans. The letter states that many veterans have, for decades, requested that medicinal marijuana…

FridayDec 16, 2022 12:00 pm

Jupiter Wellness Inc. (NASDAQ: JUPW) Is ‘One to Watch’

Jupiter Wellness’s product pipeline addresses a range of underserved conditions, including hair loss, eczema, burns, and sexual wellness The company’s revenue is generated through OTC and consumer product sales, contract research agreements, and licensing royalties Jupiter Wellness recently announced that it has been approved to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs Jupiter Wellness (NASDAQ: JUPW) is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company has a robust and growing portfolio of granted and pending patents to protect its proprietary…

FridayDec 16, 2022 4:20 am

420 with CNW — FDA Seeks More Data in Fight Against Delta-8 THC Products

The FDA is seeking more data and evidence about the safety of cannabis derivatives while touting its progress to aid agencies at state level in exposing a company that sells Delta-8 THC chewables that have “damaging” after effects. The FDA has also been criticized recently due to lack of rules allowing hemp-derived products to be marketed as diet supplements. The agency insists on the need for more data and seeks support from the legislative arm of Congress. In a data collection bid, the FDA published a fact-finding notice seeking information on the availability and capabilities of able small-business sources to…

ThursdayDec 15, 2022 4:20 pm

420 with CNW — Choking Under Illicit Cannabis, Oregon Mulls Tougher Industry Laws

Almost a decade ago, voters in the state of Oregon approved a resolution that would legalize the recreational use of cannabis. This move made it the first state in the country to do so. Many believed that the drug’s legalization would reduce problems brought about by marijuana’s illegal manufacture in the state. This has not been the case, however, with the illicit production of the drug increasingly significantly since then. Legislators are now focused on making laws against the illicit growers even stricter, having heard numerous complaints from legal growers as well as law enforcement. Various regions in the state…

ThursdayDec 15, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing the Seizure Treatment Market with Successful EPIL-A21-1 Animal Study

Epilepsy affects one in every 26 people globally, with as many as one million ED visits, 280 hospital admissions, average hospital stays of 3.6 days, and an aggregate hospital cost of approximately $2.5 billion annually With its severity, prevalence, and overall cost implications, Lexaria is looking to offer an alternative option with its patented DehydraTECH(TM)-CBD Its recent animal seizure study, EPIL-A21-1, showed DehydraTECH-CBD to be equally or even more effective at lower doses than Epidiolex, one of the world’s leading anti-seizure medications and the world’s only commercially approved CBD-powered anti-seizure drug Lexaria looks to build on the findings so far…

ThursdayDec 15, 2022 4:20 am

420 with CNW — Cannabis Sales Slow as Pandemic Eases

Marijuana sales declined across the U.S. markets after the sale spike at the onset of the pandemic. This slowdown came after the industry faced economic and regulatory tests, causing people to channel their spending money elsewhere. Small enterprises find it hard to penetrate the populated market because there isn’t sufficient investment money. The cannabis industry is also on hold, awaiting regulation by the federal government to boost its sales nationwide. Oregon and Washington states, where the cannabis market is already established, are recording low sales at the retail outlets, a cannabis data firm Headset reports. In addition, sales were 11%…

WednesdayDec 14, 2022 4:20 pm

420 with CNW — Connecticut Governor Announces Cannabis Expungements to Start in 2023

Recently, Governor Ned Lamont of Connecticut announced that the state would start clearing low-level cannabis records in 2023. The governor revealed that the state had identified more than 40,000 eligible cases for possession that would automatically be processed at the start of next year, under a provision of the marijuana legalization measure he signed in 2021. Gov. Lamont explained that old low-level marijuana possession convictions shouldn’t hinder individuals from pursuing their professional, housing, career and educational aspirations. The governor also noted that this was especially important as employers in Connecticut sought to employ hundreds of thousands. Lamont’s office has also…